Oakland, Calif. – Now that I’m on my way home from the Fourth Annual Cannabis Business Summit & Expo, there’s one statistic I just can’t stop thinking about.
And that’s a big deal.
You see, people throw around a ton of numbers at these conferences. But their true values can be incredibly opaque.
Whether the data you pick up on the Expo floor is from an entrepreneur, a lobbyist, a politician, an investment analyst, a researcher, a salesperson, or even a “brand representative,” you’ve got to do some work with it.
You’ve got to put it under the microscope, turn it around in your head, and figure out what it truly means. While most of the “tips” you get are just noise, many are interesting enough to share with friends.
But only a very, very few are truly valuable.
I’m talking about a number or statistic that flips a switch in your brain – and points your way toward future profits in your investment portfolio.
And the one number that stuck with me is this – 25%.
One of the great things about conferences – like the Marijuana Business Conference & Expo my team just attended – are the under-the-radar trends you pick up on.
The mainstream media is hardly talking about them. And the more specialized, niche coverage is busy with topics perceived as “bigger” – at least in the immediate term.
It’s the kind of valuable and credible information hanging out there on the fringes where millions are made.
And it’s why I’m personally attending the Cannabis Business Summit & Expo in Oakland, Calif., starting this upcoming Monday.
For example, at last month’s Marijuana Business Conference, a panel discussion on emerging legal marijuana markets may have flown under the radar with some inexperienced investors… but it jumped off the page to my team.
Panelist Michael Bronstein, of the law firm Bronstein & Weaver, proclaimed that New Jersey could become the most lucrative state recreational market east of the Rocky Mountains within two years. And he came equipped with plenty of data and anecdotes to back his claim up.
It makes sense.
First, New Jersey has a first-mover advantage, as none of its immediate neighbors will beat it to recreational legalization.
Plus, NJ borders two of five most populated cities in the country, New York and Philadelphia…it’s got a huge population all on its own… and it is home to communities hit hard by the decline of manufacturing looking for emerging industries like legal cannabis to bring in jobs and tax revenue.
In an effort to get tipped off on some similar profit-promising trends before I head to the Cannabis Business Summit, I spoke with a top executive of the group that sponsors that event.
I’ve repeatedly argued that legal marijuana – which will be a $24 billion industry by 2025 – is an unstoppable freight train, and that there’s hardly a thing Sessions can do about it. I’ve said it here – and to thousands of additional people who tuned in to my Pot Stock Summit last month.
I’ve come one step short of shouting it from the rooftops.
That’s no idle talk, either. As of right now, we’ve got 100% confirmation that Sessions has been totally beaten in his quest to roll back the pot prohibition clock to 1968.
Here’s how we got it: We went right into the “belly of the beast.”
When one of the largest marijuana business conferences in the country came to the Washington, D.C., area last month, my team jumped at the chance to head down I-95 to get the inside dirt.
We found that people in-the-know – politicians, former high-level government staffers, deep-pocketed investors, and even bankers – know that Sessions has already lost.
More importantly, my team talked directly with a fleet of A-list insiders who confirmed it. None was more calming than guy who literally wrote the book on federal marijuana guidance.
After a painfully quiet 2016, initial public offerings both current and future have rebounded with gusto through the first four months of 2017.
So far, 45 IPOs have priced this year – nearly three times as many as at this point last year, according to Renaissance Capital, which tracks initial offerings.
The rebound started with Snap Inc. (NYSE: SNAP)’s $3.4 billion IPO in March – and has been followed up by offerings from the likes of Cloudera Inc. (NYSE: CLDR), Okta Inc. (Nasdaq: OKTA), and Mulesoft Inc. (NYSE: MULE).
It’s been shown time and time again that the first entities to establish a strong base of business in a young and fast-growing market can reap major benefits. Being first in on an opportunity in a growth industry usually means huge profits… and leaves your competitors perennially trying to play catch-up.
The days when marijuana “edibles” were limited to a bunch of teens passing around a pan of homemade pot-laced brownies are long over.
The legal marijuana industry now grosses more than $5.4billion a year through the sale of cannabis-infused food and drinks – for people who want to avoid the harmful effects of smoking, but still want the drug’s potent effects. And as marijuana continues its march to legalization, that number will keep climbing.
That means “edibles” re one of the most lucrative legal marijuana opportunities on the market. As I told you just yesterday, according to the “inside info” I picked up from New Frontier Data, use of edibles and concentrates (that is, vaping) each nearly tripled in the last year, eating into the smokable form’s market dominance. They now compose 33% of the total market – and that number is climbing.
Now I want to show you one of my favorite speculative plays in this booming pot-stock niche. I recommended it last September in my Nova X-Report “weed investors’ bible” – The Roadmap to Marijuana Millions – and some of the peak gains we’ve seen there have been extraordinary.
In fact, I can’t think of a better way to show everyone the massive profit potential in legal weed investing.
One of my team members was at a medical marijuana insiders meeting at his home base in Maryland last week – and he got ahold of some outstanding information that’s not yet been shared with the larger public.